Evoke Wealth’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37,286
Closed -$5.39M 472
2026
Q1
$5.39M Buy
37,286
+2,516
+7% +$381K 0.1% 84
2025
Q4
$4.98M Buy
34,770
+1,065
+3% +$157K 0.09% 95
2025
Q3
$5.18M Sell
33,705
-5,231
-13% -$817K 0.1% 86
2025
Q2
$6.2M Buy
38,936
+1,804
+5% +$294K 0.14% 62
2025
Q1
$6.33M Sell
37,132
-907
-2% -$152K 0.17% 61
2024
Q4
$6.38M Buy
38,039
+4,527
+14% +$771K 0.18% 60
2024
Q3
$5.8M Buy
+33,512
New +$5.69M 0.16% 66
2024
Q2
Sell
-33,423
Closed -$5.42M 313
2024
Q1
$5.42M Buy
+33,423
New +$5.24M 0.16% 65
2023
Q4
Sell
-30,553
Closed -$4.46M 283
2023
Q3
$4.46M Buy
30,553
+974
+3% +$149K 0.16% 71
2023
Q2
$4.49M Buy
29,579
+924
+3% +$139K 0.16% 67
2023
Q1
$4.26M Sell
28,655
-321
-1% -$45.9K 0.16% 66
2022
Q4
$4.39M Buy
28,976
+169
+0.6% +$23.7K 0.16% 69
2022
Q3
$3.64M Buy
28,807
+1,086
+4% +$154K 0.15% 70
2022
Q2
$3.99M Buy
27,721
+322
+1% +$48.4K 0.15% 75
2022
Q1
$4.19M Buy
27,399
+336
+1% +$52.6K 0.14% 81
2021
Q4
$4.43M Buy
27,063
+57
+0.2% +$8.46K 0.14% 80
2021
Q3
$3.77M Buy
27,006
+1,386
+5% +$196K 0.14% 83
2021
Q2
$3.46M Buy
25,620
+6,456
+34% +$874K 0.13% 91
2021
Q1
$2.6M Buy
19,164
+11,052
+136% +$1.44M 0.12% 96
2020
Q4
$1.13M Buy
8,112
+27
+0.3% +$3.77K 0.08% 85
2020
Q3
$1.12M Sell
8,085
-22
-0.3% -$2.92K 0.09% 70
2020
Q2
$969K Buy
8,107
+405
+5% +$47.2K 0.09% 64
2020
Q1
$847K Sell
7,702
-2,056
-21% -$247K 0.12% 59
2019
Q4
$1.22M Sell
9,758
-1,714
-15% -$210K 0.15% 56
2019
Q3
$1.43M Buy
+11,472
New +$1.36M 0.18% 63

Other funds holding PG

Evoke Wealth's PG Position: Q2 2026 in Review

Evoke Wealth sold out of Procter & Gamble (PG) in Q2 2026, closing a stake of 37,286 shares — an estimated $5.39M sold.

Evoke Wealth first reported a position in PG in Q3 2019 and held it in 25 quarters. The position peaked at $6.38M in Q4 2024. 3,998 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Evoke Wealth reported no remaining Procter & Gamble position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 37,286 Procter & Gamble shares in Q2 2026, an estimated $5.39M.
  • Evoke Wealth first reported a position in Procter & Gamble in Q3 2019 and held it in 25 quarters.
  • Evoke Wealth's Procter & Gamble position peaked at $6.38M in Q4 2024.
  • 3,998 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.